OncoDaily Party Barcelona 2024
It’s another OncoDaily Party, this time at ESMO. After our successful event at ASCO, complete with an Yvonne award ceremony, we’re bringing the energy to Barcelona. Join us for a night of music, networking, and fun!
Sep 13, 2024: Event from 8:00 PM to 2:00 AM, Chiringuito Mokai Beach Bar, Barcelona, Spain.
Mark your calendar for the OncoDaily Party Barcelona 2024 on Sep 13 at Mokai Beach Bar.
OncoDaily is a US-based leading oncology media platform, which commits to providing readers with the latest news, research, and developments related to cancer on a daily basis. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
This event is by INVITATION ONLY. Please RSVP by Aug 30, 23:59, to confirm your attendance – Registration form
Sneak peak into OncoDaily party at ASCO.
OncoDaily Party 2024 Hosting Committee
Co-chairs
Giuseppe Curigliano: ESMO President elect for 2027-2028 ,Professor of Medical Oncology at the University of Milano, Chief of the Clinical Division of Early Drug Development at European Institute of Oncology, Chair of the ESMO Clinical Practice Guidelines Committee, Member of the Italian Higher Health Council
Yelena Janjigian: Chief of the Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, Associate Professor of Medicine, Weill Cornell Medical College
Gevorg Tamamyan: Editor-in-chief of OncoDaily, Professor and Chairman of the Department of Pediatric Oncology and Hematology, Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the International Society of Pediatric Oncology Asia Continental Branch (SIOP Asia), President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group
Members
Richard Sullivan: Professor of Cancer Policy & Global Health at King’s College London and Director of the Kings Institute of Cancer Policy, Co-Director of the Conflict and Health Research Group, NCD advisor to the WHO.
Paolo Tarantino: Medical Oncologist and researcher at the European Institute of Oncology and clinical research fellow at the Dana-Farber Cancer Institute.
Sara Lonardi, Chief of the Oncology 3 Unit and Chief of Phase I Clinical Trial Unit of Veneto Institute of Oncology (IOV) – IRCCS.
Julien Taieb: Head of the Gastroenterology and Gastrointestinal Oncology Department at the Georges Pompidou European Hospital, Université de Paris, Founder of the AGEO French research group on GI tumours.
Samuel J. Klempner: Head of Gastric and Esophageal Program at Massachusetts General Hospital, Associate Professor at Harvard Medical School.
Filippo Pietrantonio: GI Medical Oncologist at Fondazione IRCCS Istituto Nazionale dei Tumori.
Rana Mckay: Associate Professor of Medicine and Urology, UC San Diego School of Medicine, Co-Lead, Genitourinary Oncology Program, UC San Diego Health, Associate Director, Translational Sciences.
Herbert Loong: Clinical Associate Professor at the Department of Clinical Oncology, Deputy Medical Director, Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Honorary Consultant, Department of Clinical Oncology, Prince of Wales Hospital, Chair-Elect of the ASCO International Committee.
Rachna Shroff: Interim Clinical Affairs Director and Associate Director of Clinical Investigations of the Cancer Center, Associate Dean of Clinical and Translational Research, Chief of the Division of Hematology/Oncology and Professor at the College of Medicine, University of Arizona.
Jennifer Buell: President and CEO of MiNK Therapeutics, and Chairman of the Board at Agenus.
Davit Zohrabyan: Head of the Adult Solid Tumours and Chemotherapy Clinic at Yeolyan Oncology and Hematology Centre, ESMO Liasee in Armenia.
Jenny Seligmann: Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at the University of Leeds.
Chandler Park: Oncologist at Norton Cancer Institute and Baptist Health Hardin, Clinical Professor at the University of Louisville School of Medicine, President of the Kentucky Society of Clinical Oncology.
Martin Harutyunyan: Chief of Palliative Care Service at Yeolyan Oncology and Hematology Center.
Maryam Lustberg: Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale.
Melvin Chua Lee Kiang: Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers at the National Cancer Centre Singapore.
Petros Grivas: Clinical Director of the Genitourinary Cancers Program at University of Washington and Seattle Cancer Care Alliance, Associate Professor in the Department of Medicine, Division of Medical Oncology, and Associate Member at the Fred Hutchinson Cancer Research Center.
Ajay Aggarwal: Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Trust, London and Professor of Cancer Services & Systems Research at King’s College London.
Vivek Subbiah: Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, member of the ESMO Translational Research and Precision Medicine Working Group and Annals of Oncology Editorial Board
Amalya Sargsyan: Medical Oncologist, Yeolyan Hematology and Oncology Center.
Diana Romero: Chief Editor of Nature Reviews Clinical Oncology at Springer Nature, UK.
Florian Scotté: Head of the Interdisciplinary Department for the Organization of Patient Pathways (DIOPP) at Gustave Roussy, president-elect of MASCC (the Multinational Association for Supportive Care in Cancer).
Arturo Loaiza-Bonilla: Co-Founder and Chief Medical Officer at Massive Bio, and Medical Director of Oncology Research at Capital Health.
Ravi Karra: Vice President of Oncology at Advanced Clinical.
Karima Oualla: Professor of Medical Oncology at the Hassan II University Hospital in Morocco.
Rachel Riechelmann: Director of the Clinical Oncology Department, AC Camargo Cancer Center, Sao Paulo, Brasil, President of the Brazilian GI Tumors Group (GTG).
Onyinye Balogun: Assistant Professor of Radiation Oncology at Weill Cornell Medicine, Co-Founder/CMO Mission-Driven Tech
OncoDaily Staff
Elen Baloyan: Managing Editor of OncoDaily
Tatev Margaryan: Assistant Managing Editor of OncoDaily
For any questions or requests, please contact us at [email protected]